Adaptive pH-Sensitive Liposome Compositions for Specialized Environments
Legal Citation
Summary of the Inventive Concept
The present inventive concept relates to specialized pH-sensitive liposome compositions adapted for specific operational environments, including high-security needs, disaster relief, extreme weather conditions, high-altitude environments, and space exploration settings.
Background and Problem Solved
The original patent disclosed pH-sensitive liposome compositions for delivering molecules to cells. However, these compositions were not designed to address the unique challenges and requirements of specialized environments. The present inventive concept addresses this limitation by providing adaptive pH-sensitive liposome compositions tailored to specific operational environments, ensuring efficient and targeted delivery of therapeutic molecules.
Detailed Description of the Inventive Concept
The new inventive concept encompasses pH-sensitive liposome compositions comprising a lipid bilayer substantially free of pHLIP polypeptide. These liposomes are designed to fuse with cell membranes or endosomal compartments in response to specific pH ranges, temperature ranges, oxygen levels, or radiation levels, depending on the target environment. For example, in high-security environments, the liposomes are adapted to fuse with cell membranes at a specific pH range, ensuring secure and targeted delivery of therapeutic molecules. In disaster relief settings, the liposomes are designed to release therapeutic molecules in response to a low pH microenvironment. Similarly, in extreme weather conditions, the liposomes are adapted to deliver cargo molecules in response to specific temperature ranges.
Novelty and Inventive Step
The new inventive concept introduces a novel and non-obvious adaptation of pH-sensitive liposome compositions to specialized operational environments, providing a unique solution for efficient and targeted delivery of therapeutic molecules in these environments.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include liposomes adapted for other specialized environments, such as tropical or desert environments, or liposomes designed to respond to other environmental stimuli, such as electromagnetic fields or vibrations.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in various industries, including pharmaceuticals, biotechnology, and defense. The targeted delivery of therapeutic molecules in specialized environments could revolutionize the treatment of diseases and improve public health in these settings.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/1271 |
| A | A61 | A61K9/127 |
| A | A61 | A61K31/20 |
| A | A61 | A61K31/337 |
| A | A61 | A61K31/704 |
| A | A61 | A61K31/711 |
| A | A61 | A61K31/713 |
| A | A61 | A61K31/7105 |
| A | A61 | A61K47/6911 |
| A | A61 | A61P35/00 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical drug delivery systems, specifically liposomal compositions for targeted molecular transport, with expertise in pH-sensitive carrier technologies and cellular membrane interaction mechanisms
Person of Ordinary Skill (PHOSITA) Profile
A skilled researcher with advanced degrees in pharmaceutical sciences, biochemistry, or biomedical engineering, possessing knowledge of liposomal drug delivery, membrane interactions, and environmental responsive molecular transport systems
Obviousness Rationale
A PHOSITA would recognize that adapting pH-sensitive liposome compositions to specialized environments represents a predictable extension of the source patent's core technology of targeted molecular delivery. The fundamental mechanism of pH-triggered membrane interaction remains consistent across the variations, with environmental context serving as a mere design parameter. The technical principles of cargo delivery and membrane fusion disclosed in US 11857509 provide a clear framework for implementing similar strategies in diverse operational contexts.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,509 |
|---|---|
| Title | Liposome compositions and methods of use thereof |
| Assignee(s) | Yale University, University of Rhode Island Board of Trustees |